Clinical Trial Update: Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SHP640 to PVP-Iodine and placebo for bacterial conjunctivitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• PVP iodine (povidone-iodine)
• SHP640 (SHP640)

Snippet

Sponsor: Shire | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-28